These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6181177)

  • 21. Antitumoral action of interferon and poly(A)poly(U) on HeLa xenografts in the nude mouse.
    Rivière Y; Hovanessian AG
    Ann Immunol (Paris); 1984; 135C(3):333-43. PubMed ID: 6476791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic.polyuridylic acid.
    Youn JK; Hovanessian AG; Riviere Y; Hue G; Lacour F
    Cell Immunol; 1983 Jul; 79(2):298-308. PubMed ID: 6872004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of differentiation of mouse myeloid leukemic cells and induction of interferon in the cells by double-stranded polyribonucleotides.
    Yamamoto Y; Tomida M; Hozumi M
    Cancer Res; 1979 Oct; 39(10):4170-4. PubMed ID: 289438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
    Lacour J
    J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of polyadenylic.polyuridylic acid on cellular responses of peripheral blood mononuclear cells from patients with chronic active hepatitis B.
    Kim WH; Hahm KB; Park SJ; Kang JK; Park IS; Choi HJ; Shin JS; Youn JK
    Yonsei Med J; 1993 Sep; 34(3):258-65. PubMed ID: 8259703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of L-1210 tumor in mice toward treatment with interferon or poly(I) X poly(C).
    Rivière Y; Hovanessian A
    J Interferon Res; 1983; 3(4):417-24. PubMed ID: 6672113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer.
    Lacour F; Lacour J; Spira A; Michelson M; Delage G; Petit JY; Viguier J
    Recent Results Cancer Res; 1982; 80():200-6. PubMed ID: 7036283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p67K kinase in different tissues and plasma of control and interferon-treated mice.
    Krust B; Rivière Y; Hovanessian AG
    Virology; 1982 Jul; 120(1):240-6. PubMed ID: 6179290
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(A):poly(U); poly(O8A):poly(U); poly(A):poly(MeNH5U) and poly(O8A):poly(MeNH5U) versus Bida Semliki forest virus in chick embryos.
    Folayan JO
    Toxicol Lett; 1982 Jun; 12(1):47-52. PubMed ID: 7112601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of polyadenylic: polyuridylic acid and lipopolysaccharide on the generation of cytotoxic T lymphocytes.
    Narayanan PR; Sundharadas G
    J Exp Med; 1978 May; 147(5):1355-62. PubMed ID: 349110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the antiviral and interferon-inducing activities of poly r(A-U) by carminic acid.
    Jamison JM; Flowers DG; Jamison E; Kitareewan S; Krabill K; Rosenthal KS; Tsai C
    Life Sci; 1988; 42(15):1477-83. PubMed ID: 2451107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells.
    Liu J; Guo YM; Hirokawa M; Iwamoto K; Ubukawa K; Michishita Y; Fujishima N; Tagawa H; Takahashi N; Xiao W; Yamashita J; Ohteki T; Sawada K
    Exp Hematol; 2012 Apr; 40(4):330-41. PubMed ID: 22198151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.
    Nocera DA; Roselli E; Araya P; Nuñez NG; Lienenklaus S; Jablonska J; Weiss S; Gatti G; Brinkmann MM; Kröger A; Morón G; Maccioni M
    J Immunol; 2016 Mar; 196(6):2860-9. PubMed ID: 26880763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of entry of HIV into cells by poly(A).poly(U).
    Krust B; Callebaut C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1087-90. PubMed ID: 8312051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly A:U-induced secretion of T-lymphocyte helper factors.
    Bick PH; Johnson AG
    Scand J Immunol; 1977; 6(11):1133-44. PubMed ID: 304244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mitogenic activity of polyadenylic-polyuridyclic acid complexes.
    Han IH; Johnson AG
    Ann N Y Acad Sci; 1975 Feb; 249():370-9. PubMed ID: 1079430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1975 Nov; 35(11 Pt 1):3051-3. PubMed ID: 1182699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
    Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
    Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.